Skip to content

To evaluate the efficacy of Sarivamula Taila varti with Povidone iodine solution dressing in the post - operative management of Gudagata vidradhi within 15 days.

A Randomized Controlled Clinical Trial to evaluate the efficacy of Sarivamula Taila varti with Povidone Iodine solution in the post - operative management of Gudagata Vidradhi. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086344
Enrollment
70
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre Nigi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Patients with post-operative I & D patients of perianal abscess. ii) Age group = 18 to 40 years iii)Patient will be selected irrespective of gender

Exclusion criteria

Exclusion criteria: i)Patients with Supralevator abscess. ii)Patients with Known case of DM,TB,HIV,Ulcerative Colitis,Crohn s Disease,CA Rectum.

Design outcomes

Primary

MeasureTime frame
The effect of Sarivamula Taila varti will be accessed with the effect of Povidone Iodine solution dressing in Gudagata Vidradhi after 15 days Assessment will be done by criteria like Vranasrava(Discharge),Vranatala(Base of the wound),Vranagandha(smell),Kathinya(Indur ation),Jwar(Fever),Shula(Pain) Timepoint: Patient will be followed up on 3rd , 5th,7th,10th, and then on 16th day

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactDr Madhavi Banarase

PDEAs College of Ayurved and Research Centre,Nigdi,Pune

dr.madhavibanarase209@gmail.com9423207569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026